Table 2 Dopamine levels (pmol) in striatal dialysates collected every 15 min in mdivi-1-treated-Pink1−/− and Pink1+/+ mice.

From: Drp1 inhibition attenuates neurotoxicity and dopamine release deficits in vivo

Genotype

Treatment

n

0 min

15 min

30 min

45 min

60 min

75 min

Pink1 +/+

Vehicle

5

0.47±0.07

0.40±0.09

36.11±3.68

5.58±1.52

0.87±0.19

0.49±0.09

Pink1 −/−

Vehicle

4

0.44±0.08

0.53±0.14

15.24±3.44

1.39±0.31

0.36±0.06

0.30±0.05

Pink1 −/−

Mdivi-1

4

0.53±0.10

0.47±0.07

38.97±6.53

4.99±0.80

1.19±0.21

0.62±0.10